CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Calcitriol

骨化三醇 杂质对照品Calcitriol Impurities

EP34 个杂质条目34 impurity entries

本页汇总 骨化三醇 的 34 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 34 impurity reference standards of Calcitriol with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 骨化三醇(Calcitriol)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical MethodsSimultaneous Determination of Vitamins D3 (Calcitriol, Cholecalciferol) and K2 (Menaquinone-4 and Menaquinone-7) in Dietary Supplements by UHPLC
    Molecules (Basel, Switzerland) · 2021 · Becze A et al.  ·  PMID 34834074  ·  DOI
  2. 分析方法Analytical MethodsPharmacokinetic interaction of calcitriol with 20(S)-protopanaxadiol in mice: Determined by LC/MS analysis
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2019 · Ben-Eltriki M et al.  ·  PMID 30654110  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisPeroxygenase-Catalyzed Selective Synthesis of Calcitriol Starting from Alfacalcidol
    Antioxidants (Basel, Switzerland) · 2022 · Li Y et al.  ·  PMID 35739941  ·  DOI
  • 合成方法SynthesisStereoselective Synthesis of Four Calcitriol Lactone Diastereomers at C23 and C25
    The Journal of organic chemistry · 2019 · Nagata A et al.  ·  PMID 30985122  ·  DOI
  • 合成方法SynthesisA new approach to 19-nor-A-ring phosphine oxide for the convergent synthesis of 19-nor-calcitriol
    The Journal of steroid biochemistry and molecular biology · 2017 · Sigüeiro R et al.  ·  PMID 27592138  ·  DOI

骨化三醇 —— 原料药与杂质对照品Calcitriol — drug substance & impurities

共 35 个条目(含原料药本体)35 items incl. the drug substance
Calcitriol structure
EP原料药 APIAPI
骨化三醇Calcitriol
Calcitriol
CAS No.32222-06-3
Chemical FormulaC27H44O3
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 1(Calcitriol EP Impurity A) structure
EPA
骨化三醇杂质1(骨化三醇EP杂质A)Calcitriol Impurity 1(Calcitriol EP Impurity A)
Calcitriol Impurity 1(Calcitriol EP Impurity A)
CAS No.73837-24-8
Chemical FormulaC27H44O3
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 2(Calcitriol EP Impurity B) structure
EPB
骨化三醇杂质2(骨化三醇EP杂质B)Calcitriol Impurity 2(Calcitriol EP Impurity B)
Calcitriol Impurity 2(Calcitriol EP Impurity B)
CAS No.66791-71-7
Chemical FormulaC27H44O3
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 4 structure
4
骨化三醇杂质4Calcitriol Impurity 4
Calcitriol Impurity 4
CAS No.64190-52-9
Chemical FormulaC13H24O2
Purity>95%现货In stock
10mg25mg50mg100mg
Calcitriol Impurity 5 structure
5
骨化三醇杂质5Calcitriol Impurity 5
Calcitriol Impurity 5
CAS No.15988-11-1
Chemical FormulaC8H7N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 6 structure
6
骨化三醇杂质6Calcitriol Impurity 6
Calcitriol Impurity 6
CAS No.1428946-52-4
Chemical FormulaC28H44O3
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 8 structure
8
骨化三醇杂质8Calcitriol Impurity 8
Calcitriol Impurity 8
CAS No.171015-31-9
Chemical FormulaC13H22O
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 9 structure
9
骨化三醇杂质9Calcitriol Impurity 9
Calcitriol Impurity 9
CAS No.157809-60-4
Chemical FormulaC27H44O3
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 10 structure
10
骨化三醇杂质10Calcitriol Impurity 10
Calcitriol Impurity 10
CAS No.157809-61-5
Chemical FormulaC27H44O3
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 11 structure
11
骨化三醇杂质11Calcitriol Impurity 11
Calcitriol Impurity 11
CAS No.57102-09-7
Chemical FormulaC27H44O3
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 12 structure
12
骨化三醇杂质12Calcitriol Impurity 12
Calcitriol Impurity 12
CAS No.140710-96-9
Chemical FormulaC39H72O3Si2
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 13 structure
13
骨化三醇杂质13Calcitriol Impurity 13
Calcitriol Impurity 13
CAS No.140710-98-1
Chemical FormulaC39H72O3Si2
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 14 structure
14
骨化三醇杂质14Calcitriol Impurity 14
Calcitriol Impurity 14
CAS No.96862-25-8
Chemical FormulaC27H44O3
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 15 structure
15
骨化三醇杂质15Calcitriol Impurity 15
Calcitriol Impurity 15
CAS No.214351-86-7
Chemical FormulaC19H37IOSi
Purity>95%现货In stock
10mg25mg50mg100mg
Calcitriol Impurity 16 (Calcitroic Acid) structure
16
骨化三醇杂质16(骨化三醇酸)Calcitriol Impurity 16 (Calcitroic Acid)
Calcitriol Impurity 16 (Calcitroic Acid)
CAS No.71204-89-2
Chemical FormulaC23H34O4
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 17 structure
17
骨化三醇杂质17Calcitriol Impurity 17
Calcitriol Impurity 17
CAS No.61476-45-7
Chemical FormulaC27H44O3
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 20 structure
20
骨化三醇杂质20Calcitriol Impurity 20
Calcitriol Impurity 20
CAS No.4233-33-4
Chemical FormulaC8H5N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 21 structure
21
骨化三醇杂质21Calcitriol Impurity 21
Calcitriol Impurity 21
CAS No.157380-25-1
Chemical FormulaC27H44O3
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 24 structure
24
骨化三醇杂质24Calcitriol Impurity 24
Calcitriol Impurity 24
CAS No.147125-21-1
Chemical FormulaC39H70O4Si2
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 27 structure
27
骨化三醇杂质27Calcitriol Impurity 27
Calcitriol Impurity 27
CAS No.86307-44-0
Chemical FormulaC35H49N3O5
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 28 structure
28
骨化三醇杂质28Calcitriol Impurity 28
Calcitriol Impurity 28
CAS No.168609-17-4
Chemical FormulaC27H44O3
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 33 structure
33
骨化三醇杂质33Calcitriol Impurity 33
Calcitriol Impurity 33
CAS No.1023889-30-6
Chemical FormulaC29H46O4
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 34 structure
34
骨化三醇杂质34Calcitriol Impurity 34
Calcitriol Impurity 34
CAS No.87649-61-4
Chemical FormulaC33H58O2Si
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 35 structure
35
骨化三醇杂质35Calcitriol Impurity 35
Calcitriol Impurity 35
CAS No.98728-26-8
Chemical FormulaC33H58O3Si
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 36 structure
36
骨化三醇杂质36Calcitriol Impurity 36
Calcitriol Impurity 36
CAS No.157380-27-3
Chemical FormulaC27H44O3
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 37 structure
37
骨化三醇杂质37Calcitriol Impurity 37
Calcitriol Impurity 37
CAS No.215436-20-7
Chemical FormulaC35H45N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 38 structure
38
骨化三醇杂质38Calcitriol Impurity 38
Calcitriol Impurity 38
CAS No.215436-21-8
Chemical FormulaC37H50N4O5
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 39 structure
39
骨化三醇杂质39Calcitriol Impurity 39
Calcitriol Impurity 39
CAS No.215436-22-9
Chemical FormulaC34H51N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 40 structure
40
骨化三醇杂质40Calcitriol Impurity 40
Calcitriol Impurity 40
CAS No.215436-23-0
Chemical FormulaC34H49N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 41 structure
41
骨化三醇杂质41Calcitriol Impurity 41
Calcitriol Impurity 41
CAS No.89614-42-6
Chemical FormulaC27H44O4
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 43 structure
43
骨化三醇杂质43Calcitriol Impurity 43
Calcitriol Impurity 43
CAS No.2559769-58-1
Chemical FormulaC27H42O2
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 47 structure
47
骨化三醇杂质47Calcitriol Impurity 47
Calcitriol Impurity 47
CAS No.67869-32-3
Chemical FormulaC27H42O2
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 48 structure
48
骨化三醇杂质48Calcitriol Impurity 48
Calcitriol Impurity 48
CAS No.131249-38-2
Chemical FormulaC28H46O3
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 49 structure
49
骨化三醇杂质49Calcitriol Impurity 49
Calcitriol Impurity 49
CAS No.97473-92-2
Chemical FormulaC29H48O3
Purity>95%询价On request
10mg25mg50mg100mg
Calcitriol Impurity 50 structure
50
骨化三醇杂质50Calcitriol Impurity 50
Calcitriol Impurity 50
CAS No.105687-81-8
Chemical FormulaC28H46O3
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

骨化三醇 —— 研究文献与合成路线Calcitriol — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 骨化三醇 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Calcitriol. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Genistein-Calcitriol Mitigates Hyperosmotic Stress-Induced TonEBP, CFTR Dysfunction, VDR Degradation and Inflammation in Dry Eye Disease
    Panigrahi T, D'Souza S, Shetty R, et al. · Clinical and translational science · 2021 · 被引 21cited 21
  2. Calcitriol Inhibits HCV Infection via Blockade of Activation of PPAR and Interference with Endoplasmic Reticulum-Associated Degradation
    Lin YM, Sun HY, Chiu WT, et al. · Viruses · 2018 · 被引 13cited 13
  3. Mechanism of decreased calcitriol degradation in renal failure
    Hsu CH, Patel SR, Young EW · The American journal of physiology · 1992 · 被引 14cited 14
  4. Topical calcitriol is degraded by ultraviolet light
    Lebwohl M, Quijije J, Gilliard J, et al. · The Journal of investigative dermatology · 2003 · 被引 11cited 11
  5. Metabolic degradation and synthesis of calcitriol in spontaneously hypertensive rat
    Young EW, Hsu CH, Patel S, et al. · The American journal of physiology · 1987 · 被引 7cited 7
  6. Effect of vitamin D metabolites on calcitriol degradative enzymes in renal failure
    Patel SR, Ke HQ, Hsu CH · Kidney international · 1994 · 被引 3cited 3

合成与制备工艺专利Synthesis & process patents

  1. Preparation method of calcitriol
    MINGGANG WANG, LI REN, GUIYU SUN, YANGSHENG CHEN, et al. · 公开号 CN101607931CN101607931 · 2009
  2. Calcitriol dripping pill and preparation method thereof
    MINGGANG WANG, LI REN, YANGSHENG CHEN · 公开号 CN101554372CN101554372 · 2009
  3. Method and device for preparing calcitriol by utilizing photochemical reaction
    MINGGANG WANG, LI REN, YANGSHENG CHEN, GUIYU SUN · 公开号 CN101607932CN101607932 · 2009
  4. USE OF PROSTAGLANDIN E1 FOR INCREASING THE CALCITRIOL SYNTHESIS AND ACCELERATING THE BONE MINERALIZATION IN FRACTURES
    FORERO FRANCISCO HERNANY VELAZUEZ · 公开号 MX2008015777MX2008015777 · 2009
  5. STARTING COMPOUNDS FOR PREPARING CALCITRIOL AND ITS DERIVATIVES, METHOD FOR PREPARING THESE STARTING COMPOUNDS AND INTERMEDIATE PRODUCTS FOR THIS METHOD
    SCHÖNECKER Bruno, DROESCHER Peter, ADAM Günter, MARQUARDT Volker, et al. · 公开号 WO9214746WO9214746 · 1992

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

骨化三醇 杂质谱研究要点Calcitriol — impurity profiling notes

下面这些是拿到 骨化三醇 的 35 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 35 impurity entries for Calcitriol, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances